Home/Filings/4/0000919574-20-005947
4//SEC Filing

CDK ASSOCIATES, L.L.C. 4

Accession 0000919574-20-005947

CIK 0001634432other

Filed

Sep 20, 8:00 PM ET

Accepted

Sep 21, 9:48 PM ET

Size

11.2 KB

Accession

0000919574-20-005947

Insider Transaction Report

Form 4
Period: 2020-09-17
Transactions
  • Purchase

    Ordinary Shares, $0.01 par value

    2020-09-17$2.25/sh+1,473,377$3,315,0988,054,682 total
  • Purchase

    Ordinary Shares, $0.01 par value

    2020-09-18$2.20/sh+6,000$13,2008,060,682 total
CAXTON CORP
10% Owner
Transactions
  • Purchase

    Ordinary Shares, $0.01 par value

    2020-09-18$2.20/sh+6,000$13,2008,060,682 total
  • Purchase

    Ordinary Shares, $0.01 par value

    2020-09-17$2.25/sh+1,473,377$3,315,0988,054,682 total
Kovner Bruce
10% Owner
Transactions
  • Purchase

    Ordinary Shares, $0.01 par value

    2020-09-17$2.25/sh+1,473,377$3,315,0988,054,682 total
  • Purchase

    Ordinary Shares, $0.01 par value

    2020-09-18$2.20/sh+6,000$13,2008,060,682 total
Footnotes (2)
  • [F1]Following the transactions reported herein, these shares represent (a) 7,529,834 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 530,848 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.24 to $2.25 per share, inclusive. The Reporting Persons undertake to provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Documents

1 file

Issuer

Strongbridge Biopharma plc

CIK 0001634432

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001576081

Filing Metadata

Form type
4
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 9:48 PM ET
Size
11.2 KB